LONDON and SEATTLE—Tenpoint Therapeutics, Ltd., a global commercial ophthalmic pharmaceutical company with a focus on vision in the aging eye, has announced the appointment of Stephen S. Lane, MD, as chief medical officer (CMO), effective immediately. In this role, Dr. Lane will join the executive team and oversee the company’s clinical development strategy, medical affairs and pharmacovigilance, the company said. Dr. Lane brings significant ophthalmology leadership experience in both clinical practice and the pharmaceutical industry, most recently serving as chief medical officer and head of medical safety at Alcon, according to Tenpoint Therapeutics.